Asymmetric Outcomes of Type 1 Retinopathy of Prematurity after Bilateral Intravitreal Ranibizumab Treatment

Purpose. To present cases with retinopathy of prematurity (ROP), who were treated with intravitreal injection of ranibizumab (IVR) and had unpredictable asymmetric outcomes. Methods. A retrospective review was performed in infants with type 1 ROP and had bilateral IVR (0.25 mg/0.025 mL) as initial t...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Qiujing, Zhang, Qi, Xu, Yu, Ji, Xunda, Fei, Ping, Peng, Jie, Li, Yi-an, Zhao, Peiquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5390587/
https://www.ncbi.nlm.nih.gov/pubmed/28465833
http://dx.doi.org/10.1155/2017/1741386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5390587/
https://www.ncbi.nlm.nih.gov/pubmed/28465833
http://dx.doi.org/10.1155/2017/1741386

Ejemplares similares